Physician profile
Nancy Ramirez
NPI 1285277558
$1,036.35
in general payments reported to CMS, 2019-2025
9 companies · $46.63 in 2025
The $46.63 reported for 2025 was less than what a typical Acute Care (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $137).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $497 · 2022: $91.07 · 2023: $273 · 2024: $128 · 2025: $46.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $447.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $395.63 | 2021 | |
| Travere Therapeutics, INC. | $150.75 | 2024-2025 | |
| Horizon Therapeutics Plc | $103.73 | 2023 | Krystexxa |
| Galderma Laboratories, L.P. | $92.09 | 2023 | |
| Vifor Pharma, INC. | $75.89 | 2022-2023 | Korsuva, Veltassa |
| Otsuka America Pharmaceutical, INC. | $72.04 | 2021 | |
| Novo Nordisk INC | $69.12 | 2022 | |
| Amgen INC. | $53.57 | 2021-2025 | Krystexxa |
| Angiodynamics, INC. | $23.53 | 2023 | Auryon Laser System 100-120 Vac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.